|
|
|
42
|
1162AB
|
HYDRALLAZINE 50MG TAB (FSB)
|
HYDRALLAZINE
|
HYDRALLAZINE
|
10X10
|
A
|
8.29
|
0.08
|
TAB
|
60
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
B
|
240820
|
DIRECT VASODILATOR
|
2026-04-01
|
|
Add to Contract as Cat A
|
ORAL
|
6
|
DIRECT VASODILATOR
|
2026-03-05
|
|
|
|
40
|
1162T
|
HYDRALLAZINE 50MG TAB (FSB/ATB)
|
HYDRALLAZINE
|
HYDRALLAZINE
|
25X10
|
A
|
32.62
|
0.13
|
TABLET
|
60
|
TAB
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
240820
|
DIRECT VASODILATOR
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
11637
|
HYDRALLAZINE 20MG/ML INJ (FSB) (B)
|
HYDRALLAZINE
|
HYDRALLAZINE
|
20MG VIAL
|
B
|
38.11
|
38.1109
|
VIAL
|
0
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
240820
|
DIRECT VASODILATOR
|
2024-04-01
|
2026-03-31
|
|
|
0
|
DIRECT VASODILATOR
|
|
|
|
|
40
|
1163H
|
HYDRALLAZINE 20MG/ML INJ (MON/PHA)
|
HYDRALLAZINE
|
HYDRALLAZINE
|
10X1ML
|
B
|
43.17
|
4.32
|
INJECTION
|
0
|
VIAL
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
240820
|
DIRECT VASODILATOR
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
1163J
|
LAHYZINE 20MG/ML INJ (LDP/AHI) HYDRALLAZINE
|
HYDRALLAZINE
|
LAHYZINE
|
20MG VIAL
|
B
|
5.71
|
5.71
|
INJECTION
|
0
|
VIAL
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240820
|
DIRECT VASODILATOR
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1163K
|
HYDRALLAZINE 20MG/ML INJ (DIL) (B)
|
HYDRALLAZINE
|
HYDRALLAZINE
|
25X1ML
|
B
|
938.75
|
37.5498
|
VIAL
|
0
|
BOX
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240820
|
DIRECT VASODILATOR
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
DIRECT VASODILATOR
|
|
|
|
|
40
|
1171V
|
ALDOMET 250MG TAB (ASG/STO) METHYLDOPA
|
METHYLDOPA
|
ALDOMET
|
30'S
|
A
|
5.44
|
0.18
|
TABLET
|
180
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
240816
|
CENTRAL ALPHA ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1171V
|
ALDOMET 250MG TAB (ASG) METHYLDOPA
|
METHYLDOPA
|
ALDOMET
|
30'S
|
A
|
11.63
|
0.3878
|
TAB
|
180
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
240816
|
CENTRAL ALPHA ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
CENTRAL ALPHA ANTAGONIST
|
|
|
|
|
42
|
1171V
|
ALDOMET 250MG TAB (ASG) METHYLDOPA
|
METHYLDOPA
|
ALDOMET
|
30'S
|
A
|
13.65
|
0.46
|
TAB
|
180
|
BLIS
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
240816
|
CENTRAL ALPHA ANTAGONIST
|
2026-04-01
|
|
|
ORAL
|
6
|
CENTRAL ALPHA ANTAGONIST
|
|
|
|
|
40
|
1172K
|
ALDOMET 500MG TAB (ASG/STO) METHYLDOPA
|
METHYLDOPA
|
ALDOMET
|
30'S
|
A
|
8.83
|
0.29
|
TABLET
|
180
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
240816
|
CENTRAL ALPHA ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1172K
|
ALDOMET 500MG TAB (ASG) METHYLDOPA
|
METHYLDOPA
|
ALDOMET
|
30'S
|
A
|
19.03
|
0.6343
|
TAB
|
180
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
240816
|
CENTRAL ALPHA ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
CENTRAL ALPHA ANTAGONIST
|
|
|
|
|
42
|
1172K
|
ALDOMET 500MG TAB (ASG) METHYLDOPA
|
METHYLDOPA
|
ALDOMET
|
30'S
|
A
|
22.32
|
0.74
|
TAB
|
180
|
BLIS
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
240816
|
CENTRAL ALPHA ANTAGONIST
|
2026-04-01
|
|
|
ORAL
|
6
|
CENTRAL ALPHA ANTAGONIST
|
|
|
|
|
40
|
11816
|
CONCOR 2.5MG TAB (MEK/COL) BISOPROLOL
|
BISOPROLOL
|
CONCOR
|
30'S
|
C
|
28.81
|
0.96
|
TABLET
|
0
|
TAB
|
MEK
|
MERCK SERONO
|
COL
|
COLLINS LTD
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
11816
|
CONCOR 2.5MG TAB (MEK) BISOPROLOL (C)
|
BISOPROLOL
|
CONCOR
|
30'S
|
C
|
28.81
|
0.9605
|
TAB
|
30
|
BOX
|
MEK
|
MERCK SERONO
|
COL
|
COLLINS LTD
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
42
|
11816
|
CONCOR 2.5MG TAB (MEK) BISOPROLOL
|
BISOPROLOL
|
CONCOR
|
30'S
|
C
|
30.28
|
1.01
|
TAB
|
30
|
BLIS
|
MEK
|
MERCK SERONO
|
COL
|
AVENTA BARBADOS
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2026-04-01
|
|
|
ORAL
|
6
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
40
|
1181AJ
|
APO-SOTALOL 80MG TAB (APO/COL)
|
SOTALOL
|
APO-SOTALOL
|
100'S
|
A
|
10.87
|
0.11
|
TABLET
|
90
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
42
|
1181AJ
|
APO-SOTALOL 80MG TAB (APO)
|
SOTALOL
|
APO-SOTALOL
|
100'S
|
A
|
11.09
|
0.11
|
TAB
|
90
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2026-04-01
|
|
|
ORAL
|
6
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
41
|
1181CF
|
PMS-SOTALOL 80MG TAB (PMS)
|
SOTALOL
|
SOTALOL
|
100'S
|
A
|
17.67
|
0.1767
|
TAB
|
90
|
BOTT
|
PMS
|
PHARMASCIENCE
|
COL
|
COLLINS LTD
|
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
40
|
1181EF
|
BISOPROLOL 2.5MG TAB (FSB/ATB)
|
BISOPROLOL
|
BISOPROLOL
|
10X10
|
A
|
3.70
|
0.04
|
TABLET
|
30
|
TAB
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-07
|
2022-09-30
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-04-07
|
|
|
|
40
|
1181EV
|
CILENOL 2.5MG TAB (CIR/AHI) BISOPROLOL
|
BISOPROLOL
|
CILENOL
|
30'S
|
A
|
2.75
|
0.09
|
TABLET
|
30
|
TAB
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-03-29
|
